Extracellular Vesicle Manufacturing Market
完整報告名稱與涵蓋範圍
Extracellular Vesicle Manufacturing Market Size, Share & Trends Analysis Report, By Offering (Upstream Production Systems and Cell Culture Platforms, Isolation and Purification Technologies, Characterization and Quality Control Analytics, Contract Development and Manufacturing Services), By Vesicle Source (Mesenchymal Stem Cell-Derived, Engineered Producer Cell Lines, Plant, Bacterial and Other Sources), By Application (Therapeutics, Regenerative Medicine and Aesthetics, Diagnostics and Research), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The extracellular vesicle manufacturing market covers the upstream production systems, isolation and purification technologies, characterisation and quality control analytics and contract development and manufacturing services used to produce exosomes and other extracellular vesicles for therapeutics, regenerative medicine and aesthetics, and diagnostics and research. Finished exosome consumer products and diagnostic tests are addressed in other studies and excluded here.
Manufacturing has become the gating factor for the field: therapeutic doses may require trillions of vesicles, heterogeneity complicates potency definition and traditional ultracentrifugation does not scale. Suppliers are responding with high-density bioreactors and hollow-fibre systems for mesenchymal stem cell production, engineered producer lines that yield vesicles loaded with defined cargo, tangential flow filtration and chromatography workflows adapted from viral vector purification, and analytical platforms combining nanoparticle tracking, flow cytometry and mass spectrometry to define critical quality attributes. Regulatory guidance for vesicle-based products is still emerging, and the largest commercial volumes currently serve aesthetics and research while clinical programs advance in immunology, neurology and regenerative indications.
North America, Europe and South Korea lead in tools and manufacturing capacity, with Japan and China active in research and aesthetic production. Competition involves bioprocess suppliers, exosome therapeutics companies with in-house platforms, analytical instrument makers and specialised CDMOs.
The InsightAce study includes revenue forecasts in US$ for all offering, vesicle source, application and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Extracellular Vesicle Manufacturing Market Snapshot
Chapter 4. Global Extracellular Vesicle Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis
5.1. Offering & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Offering:
5.2.1. Upstream Production Systems and Cell Culture Platforms
5.2.2. Isolation and Purification Technologies
5.2.3. Characterization and Quality Control Analytics
5.2.4. Contract Development and Manufacturing Services
Chapter 6. Market Segmentation 2: By Vesicle Source Estimates & Trend Analysis
6.1. Vesicle Source & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Vesicle Source:
6.2.1. Mesenchymal Stem Cell-Derived
6.2.2. Engineered Producer Cell Lines
6.2.3. Plant, Bacterial and Other Sources
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Therapeutics
7.2.2. Regenerative Medicine and Aesthetics
7.2.3. Diagnostics and Research
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Biotechnology and Pharmaceutical Companies
8.2.2. Academic and Research Institutes
8.2.3. Aesthetic and Consumer Product Manufacturers
Chapter 9. Extracellular Vesicle Manufacturing Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. RoosterBio, Inc.
11.2. Lonza Group AG
11.3. Cytiva (Danaher)
11.4. Sartorius AG
11.5. Evox Therapeutics Ltd.
11.6. Capricor Therapeutics, Inc.
11.7. Direct Biologics, LLC
11.8. Aegle Therapeutics Corp.
11.9. ExoCoBio Inc.
11.10. Thermo Fisher Scientific Inc.
11.11. Merck KGaA (MilliporeSigma)
11.12. Particle Metrix GmbH
11.13. NanoFCM Co., Ltd.
11.14. Exopharm Limited
11.15. Ilias Biologics Inc.
圖表清單 List of Tables & Figures
Table 1. Global Extracellular Vesicle Manufacturing Market Revenue Forecast by Offering, 2026-2035 (US$ Mn)
Figure 1. Global Extracellular Vesicle Manufacturing Market Segmentation and Scope Overview
Table 2. Global Extracellular Vesicle Manufacturing Market Revenue Forecast by Vesicle Source, 2026-2035 (US$ Mn)
Figure 2. Global Extracellular Vesicle Manufacturing Market Share by Offering, 2026 & 2035
Table 3. Global Extracellular Vesicle Manufacturing Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Scalable Extracellular Vesicle Production and Purification Workflow
Table 4. Global Extracellular Vesicle Manufacturing Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Characterization Technologies for Defining Vesicle Critical Quality Attributes
Table 5. Global Extracellular Vesicle Manufacturing Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Extracellular Vesicle Manufacturing Growth Opportunity Analysis
Table 6. North America Extracellular Vesicle Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Extracellular Vesicle Manufacturing Market Participants
Table 7. Europe Extracellular Vesicle Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Extracellular Vesicle Manufacturing Market
Table 8. Asia Pacific Extracellular Vesicle Manufacturing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Demand Split Between Therapeutic, Aesthetic and Research Vesicle Manufacturing, 2026-2035
Table 9. Strategic Developments of Leading Extracellular Vesicle Manufacturing Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們